Literature DB >> 11278317

The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein.

M Vivo1, R A Calogero, F Sansone, V Calabrò, T Parisi, L Borrelli, S Saviozzi, G La Mantia.   

Abstract

The INK4a gene, one of the most often disrupted loci in human cancer, encodes two unrelated proteins, p16(INK4a) and p14(ARF) (ARF) both capable of inducing cell cycle arrest. Although it has been clearly demonstrated that ARF inhibits cell cycle via p53 stabilization, very little is known about the involvement of ARF in other cell cycle regulatory pathways, as well as on the mechanisms responsible for activating ARF following oncoproliferative stimuli. In search of factors that might associate with ARF to control its activity or its specificity, we performed a yeast two-hybrid screen. We report here that the human homologue of spinophilin/neurabin II, a regulatory subunit of protein phosphatase 1 catalytic subunit specifically interacts with ARF, both in yeast and in mammalian cells. We also show that ectopic expression of spinophilin/neurabin II inhibits the formation of G418-resistant colonies when transfected into human and mouse cell lines, regardless of p53 and ARF status. Moreover, spinophilin/ARF coexpression in Saos-2 cells, where ARF ectopic expression is ineffective, somehow results in a synergic effect. These data demonstrate a role for spinophilin in cell growth and suggest that ARF and spinophilin could act in partially overlapping pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278317     DOI: 10.1074/jbc.M006845200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  The actin-binding domain of spinophilin is necessary and sufficient for targeting to dendritic spines.

Authors:  Stacie D Grossman; Linda C Hsieh-Wilson; Patrick B Allen; Angus C Nairn; Paul Greengard
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

2.  A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.

Authors:  Jialiang Wang; Xiaping He; Ying Luo; Wendell G Yarbrough
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

3.  ARF function does not require p53 stabilization or Mdm2 relocalization.

Authors:  Chandrashekhar Korgaonkar; Lili Zhao; Modestos Modestou; Dawn E Quelle
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Angiotensin IV upregulates the activity of protein phosphatase 1α in Neura-2A cells.

Authors:  Dan Wang; Peng Xue; Xiu Lan Chen; Zhen Sheng Xie; Fu Quan Yang; Li Zheng; Tao Xu
Journal:  Protein Cell       Date:  2013-06-06       Impact factor: 14.870

5.  Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.

Authors:  I Ferrer; E M Verdugo-Sivianes; M A Castilla; R Melendez; J J Marin; S Muñoz-Galvan; J L Lopez-Guerra; B Vieites; M J Ortiz-Gordillo; J M De León; J M Praena-Fernandez; M Perez; J Palacios; A Carnero
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

6.  Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Authors:  David Bertwistle; Masataka Sugimoto; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family.

Authors:  Viola Calabrò; Gelsomina Mansueto; Raffaela Santoro; Antonio Gentilella; Alessandra Pollice; Pamela Ghioni; Luisa Guerrini; Girolama La Mantia
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 8.  Role of the Holoenzyme PP1-SPN in the Dephosphorylation of the RB Family of Tumor Suppressors During Cell Cycle.

Authors:  Eva M Verdugo-Sivianes; Amancio Carnero
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

9.  Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.

Authors:  A Aigelsreiter; A L Ress; K Bettermann; S Schauer; K Koller; F Eisner; T Kiesslich; T Stojakovic; H Samonigg; P Kornprat; C Lackner; J Haybaeck; M Pichler
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

10.  Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.

Authors:  Maria Vivo; Michela Ranieri; Federica Sansone; Cristina Santoriello; Raffaele A Calogero; Viola Calabrò; Alessandra Pollice; Girolama La Mantia
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.